• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·UK·Consumer Cyclical·REL.L
Held by 2 Gurus
Share

RELX Plc Stocks

£ 2599Last Updated 07.10.2026

Issuer Rating

6/7
Performance

Favourable

Risk

Low

Recommendation

Buy

Market Cap

£ 58.44B

£ 2599
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

In Guru Portfolios

Steven Cohen

Portfolio Weight (%)

0.0%

Change

+0.01%

Fund

Point72 Asset Management, L.P.

Kenneth Griffin

Portfolio Weight (%)

0.0%

Change

-0.00%

Fund

CITADEL ADVISORS LLC

Manager
Fund
Portfolio Weight (%)
Change
Steven CohenPoint72 Asset Management, L.P.0.0%+0.01%
Kenneth GriffinCITADEL ADVISORS LLC0.0%-0.00%

Latest news

27.01.2026 18:10

UBS shares top European picks ahead of earnings season, incl. three small caps

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

RELX PLC is a global enterprise that furnishes professional and business clients with sophisticated information-based analytics and decision-making instruments across North America, Europe, and other international markets. Its operations are organized into four primary divisions: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment delivers advanced analytical and decision-support tools by integrating public and industry-specific content with cutting-edge technology and algorithms, empowering clients to evaluate and predict risks effectively. Through its Scientific, Technical & Medical segment, the company provides essential information and analytical insights, enabling institutions and professionals to foster scientific progress and enhance healthcare worldwide. The Legal segment offers comprehensive legal, regulatory, and commercial information alongside analytics, assisting customers in making well-informed decisions and boosting their operational efficiency. Furthermore, the Exhibitions segment manages a dynamic events portfolio, combining in-person interactions with data-driven and digital solutions to help attendees understand markets, source products, and finalize business transactions. Founded in 1903 and headquartered in London, United Kingdom, the organization operated as Reed Elsevier PLC before adopting the RELX PLC name in July 2015.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, reasonab

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of REL.L is 3569 and suggests 37.3% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

09.10.2026 07:30

Trump disclosed major trades in SpaceX and Nvidia stocks and awarded their CEOs medals

09.10.2026 05:11

Lukoil's overseas assets are once again up for sale: the deal with Carlyle fell through

09.10.2026 03:50

Blue Origin funding round makes Bezos world’s second-richest person

09.10.2026 02:09

SpaceX Takes on AT&T and Verizon: Starlink Could Become a Major Cell Phone Carrier

09.10.2026 01:06

OpenAI revenue disappointment hits AI stocks, sending Nasdaq 100 down more than 1%

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026